Common Disease
Background Diabetic Retinopathy
Alias:
Non Proliferative Diabetic Retinopathy
Non-Proliferative Diabetic Retinopathy
Nonproliferative Diabetic Retinopathy
Cardiovascular diseases
Neuronal diseases
Basic Information
Medical Symptom
Age Of Onset
Related Gene
Drugs
Disease Model
Basic Information
Background Diabetic Retinopathy, also known as non proliferative diabetic retinopathy, is related to microvascular complications of diabetes 1 and severe nonproliferative diabetic retinopathy. An important gene associated with Background Diabetic Retinopathy is VEGFA (Vascular Endothelial Growth Factor A), and among its related pathways/superpathways are TGF-Beta Pathway and p70S6K Signaling. The drugs Benzocaine and Tannic acid have been mentioned in the context of this disorder. Affiliated tissues include endothelial and eye, and related phenotypes are homeostasis/metabolism and neoplasm
Related Disease
No other diseases associated with this disorder
About Background Diabetic Retinopathy
Related ID:
Inheritance:Others
Age Of Onset:The onset time of the disease is currently uncertain.
Prevalence:The incidence rate of this disease is currently unclear.
Related Gene:
Disease Model:
Medical Symptom
Even among those with the same illness, each patient's condition and symptoms are unique. To provide patient-centered medical care, medical professionals must carefully evaluate individual differences between patients. This involves thorough assessment of medical details when diagnosing and developing treatment plans. To achieve personalized and maximally effective care, practitioners refer to the latest research and standards of care to tailor treatment strategies for each patient.
Age Of Onset
The symptoms and onset times of different diseases vary significantly because of a variety of factors, including genetics, environment, lifestyle, etc. While some illnesses may not show symptoms until later in life, others may. Furthermore, the age at which a disease manifests varies according to its nature. For these reasons, knowledge of the signs and timing of the disease is essential to diagnosis and prompt treatment.
Related Gene
Even among those with the same illness, each patient's condition and symptoms are unique. To provide patient-centered medical care, medical professionals must carefully evaluate individual differences between patients. This involves thorough assessment of medical details when diagnosing and developing treatment plans. To achieve personalized and maximally effective care, practitioners refer to the latest research and standards of care to tailor treatment strategies for each patient.
Drugs
Gene target medications are a novel form of treatment that can alter genes or proteins while also blocking disease processes. It precisely detects and chooses target proteins in order to induce therapeutic effects. Target medications are categorized into several groups based on disease causes and molecular foundation, and numerous ways are employed to treat illnesses.
Name
CAS Number
Status
Phase
No data available
Disease Model
The mouse disease model refers to the manipulation of the mouse genome through gene editing and other techniques, enabling it to carry a specific disease gene or lack an important gene. This provides an experimental platform for researching the mechanism of disease occurrence, drug development, and treatment efficacy.
BioGPT